Aquestive Therapeutic

AQST

3.6802.22% ( +0.080 )

Trading: Jul 30, 10:37:45 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Aquestive Therapeutic(AQST) predict that the Revenue is 14.45 M (+65.67%), Beat estimate;the EBIT is -4.204 M (+78.29%), Beat estimate;the EPS is -0.07 (+70.83%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.01B65.67%

0.01B24.95%

+0.00B40.72%

EBITExceed expectations

-0.00B78.29%

-0.01B25.68%

+0.01B52.61%

EPSExceed expectations

-0.0770.83%

-0.137142.86%

+0.067127.97%

Upcoming earnings report - FY2026 Q2 Earning Release

Available dateAug 11, 2026

Estimate Revenue11.56 M

Estimate EBIT-9.636 M

Estimate EPS-0.1042

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD